108 related articles for article (PubMed ID: 22498927)
1. Spironolactone, but not eplerenone, impairs glucose tolerance in a rat model of metabolic syndrome.
Homma T; Fujisawa M; Arai K; Ishii M; Sada T; Ikeda M
J Vet Med Sci; 2012 Aug; 74(8):1015-22. PubMed ID: 22498927
[TBL] [Abstract][Full Text] [Related]
2. The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism.
Eudy RJ; Sahasrabudhe V; Sweeney K; Tugnait M; King-Ahmad A; Near K; Loria P; Banker ME; Piotrowski DW; Boustany-Kari CM
J Transl Med; 2011 Oct; 9():180. PubMed ID: 22017794
[TBL] [Abstract][Full Text] [Related]
3. Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism.
Karashima S; Yoneda T; Kometani M; Ohe M; Mori S; Sawamura T; Furukawa K; Seta T; Yamagishi M; Takeda Y
Hypertens Res; 2016 Mar; 39(3):133-7. PubMed ID: 26606875
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone Synthase Inhibition Improves Glucose Tolerance in Zucker Diabetic Fatty (ZDF) Rats.
Hofmann A; Brunssen C; Peitzsch M; Martin M; Mittag J; Jannasch A; Engelmann F; Brown NF; Weldon SM; Huber J; Streicher R; Deussen A; Eisenhofer G; Bornstein SR; Morawietz H
Endocrinology; 2016 Oct; 157(10):3844-3855. PubMed ID: 27526033
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism.
Wang M; Li Y; Zhou K; Zhang G; Wang Y; Liu T; Zhang Y; Guo A; An Y
Cell Physiol Biochem; 2016; 39(3):860-70. PubMed ID: 27497962
[TBL] [Abstract][Full Text] [Related]
6. Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance.
Wada T; Ishikawa A; Watanabe E; Nakamura Y; Aruga Y; Hasegawa H; Onogi Y; Honda H; Nagai Y; Takatsu K; Ishii Y; Sasahara M; Koya D; Tsuneki H; Sasaoka T
J Endocrinol; 2017 Dec; 235(3):179-191. PubMed ID: 28855315
[TBL] [Abstract][Full Text] [Related]
7. DSR-71167, a novel mineralocorticoid receptor antagonist with carbonic anhydrase inhibitory activity, separates urinary sodium excretion and serum potassium elevation in rats.
Nariai T; Fujita K; Kawane K; Mori M; Nakayama R; Matsuda K; Katayama S; Fukuda N; Hori S; Iwata M; Hasegawa F; Suzuki K; Kato H
J Pharmacol Exp Ther; 2015 Jul; 354(1):2-9. PubMed ID: 25922341
[TBL] [Abstract][Full Text] [Related]
8. SM-368229, a novel selective and potent non-steroidal mineralocorticoid receptor antagonist with strong urinary Na+ excretion activity.
Nariai T; Fujita K; Mori M; Katayama S; Hori S; Matsui K
J Pharmacol Sci; 2011; 115(3):346-53. PubMed ID: 21358118
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone-induced degradation of the TFIIH core complex XPB subunit suppresses NF-κB and AP-1 signalling.
Elinoff JM; Chen LY; Dougherty EJ; Awad KS; Wang S; Biancotto A; Siddiqui AH; Weir NA; Cai R; Sun J; Preston IR; Solomon MA; Danner RL
Cardiovasc Res; 2018 Jan; 114(1):65-76. PubMed ID: 29036418
[TBL] [Abstract][Full Text] [Related]
10. The effects of aldosterone on diet-induced fatty liver formation in male C57BL/6 mice: comparison of adrenalectomy and mineralocorticoid receptor blocker.
Gamliel-Lazarovich A; Raz-Pasteur A; Coleman R; Keidar S
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1086-92. PubMed ID: 23524523
[TBL] [Abstract][Full Text] [Related]
11. Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction.
Schäfer A; Fraccarollo D; Hildemann SK; Tas P; Ertl G; Bauersachs J
Cardiovasc Res; 2003 Jun; 58(3):655-62. PubMed ID: 12798439
[TBL] [Abstract][Full Text] [Related]
12. The mineralocorticoid receptor antagonist eplerenone reduces renal interstitial fibrosis after long-term cyclosporine treatment in rat: antagonizing cyclosporine nephrotoxicity.
Nielsen FT; Jensen BL; Hansen PB; Marcussen N; Bie P
BMC Nephrol; 2013 Feb; 14():42. PubMed ID: 23425330
[TBL] [Abstract][Full Text] [Related]
13. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress.
Nagase M; Matsui H; Shibata S; Gotoda T; Fujita T
Hypertension; 2007 Nov; 50(5):877-83. PubMed ID: 17875821
[TBL] [Abstract][Full Text] [Related]
14. Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension.
Takeda Y
Hypertens Res; 2009 May; 32(5):321-4. PubMed ID: 19300447
[TBL] [Abstract][Full Text] [Related]
15. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors.
Nagase M; Yoshida S; Shibata S; Nagase T; Gotoda T; Ando K; Fujita T
J Am Soc Nephrol; 2006 Dec; 17(12):3438-46. PubMed ID: 17082236
[TBL] [Abstract][Full Text] [Related]
16. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor.
Rogerson FM; Yao Y; Smith BJ; Fuller PJ
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):704-9. PubMed ID: 15554912
[TBL] [Abstract][Full Text] [Related]
17. Prostate effect in dogs with the aldosterone receptor blocker eplerenone.
Levin S; McMahon E; John-Baptiste A; Bell RR
Toxicol Pathol; 2013 Feb; 41(2):271-9. PubMed ID: 23242577
[TBL] [Abstract][Full Text] [Related]
18. Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone.
Lainscak M; Pelliccia F; Rosano G; Vitale C; Schiariti M; Greco C; Speziale G; Gaudio C
Int J Cardiol; 2015 Dec; 200():25-9. PubMed ID: 26404748
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone aggravates glucose intolerance induced by high fructose.
Sherajee SJ; Rafiq K; Nakano D; Mori H; Kobara H; Hitomi H; Fujisawa Y; Kobori H; Masaki T; Nishiyama A
Eur J Pharmacol; 2013 Nov; 720(1-3):63-8. PubMed ID: 24201309
[TBL] [Abstract][Full Text] [Related]
20. Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways?
Hermidorff MM; Faria Gde O; Amâncio Gde C; de Assis LV; Isoldi MC
Biochem Cell Biol; 2015 Feb; 93(1):83-93. PubMed ID: 25488178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
